Search
for
Sort by
Research 151–180 of 1000+
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- The potential of regulatory T cell-based therapies for alopecia areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- γδ T Cells Mediate a Requisite Portion of a Wound Healing Response Triggered by Cutaneous Poxvirus Infection
- Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Natural killer cells in atopic and autoimmune diseases of the skin
- Regulatory T cells in skin regeneration and wound healing
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Stem cell-based therapies for alopecia areata: a narrative review
- Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- Mechanism of PPARα agonist in alopecia areata
- 1365 Interest of Biotrinine®, a mix of Nasturtium officinale and Tropaeolum majus extracts, for chronic hair loss treatment
- MHC Class I-Like MILL Molecules Are β2-Microglobulin-Associated, GPI-Anchored Glycoproteins That Do Not Require TAP for Cell Surface Expression
- 097 LFA-1 blockade prevents the onset of alopecia areata in C3H/HeJ mice
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata
- Novel potential therapeutic targets of alopecia areata
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?
- Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata
- Alopecia areata: medical treatments
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata